Activated skin mast cells are involved in murine hair follicle regression (Catagen)

Laboratory Investigation

Volumn 77, Issue 4, 1997, Pages 319-332

  Maurer, Marcus ^a   Fischer, Evalies ^a   Handjiski, Bori ^a   Von Stebut, Esther ^a   Algermissen, Bernd ^a   Bavandi, Assad ^b   Paus, Ralf ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b NOVARTIS RESEARCH INSTITUTE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ELECTRON MICROSCOPY; FEMALE; HAIR DISEASE; HAIR FOLLICLE; HISTOCHEMISTRY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; CROMOLYN SODIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HAIR FOLLICLE; IMMUNOHISTOCHEMISTRY; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, ELECTRON; QUINAZOLINES; SKIN PHYSIOLOGY; SUBSTANCE P;

EID: 0030661880     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (93)

1. Algermissen B, Bauer F, Schadendorf D, Kropp J-D, and Czarnetzki BM (1994). Analysis of mast cell subpopulations (MCT, MCTC) in cutaneous inflammation using novel enzyme-histochemical staining techniques. Exp Dermatol 3:290-297.
2. Alving K, Sundström C, Matran R, Panula P, Hökfelt T, and Lundberg JM (1991). Association between histamine-containing mast cells and sensory nerves in the skin and airways of control and capsaicin-treated pigs. Cell Tissue Res 264:529-538.
3. Ansel JC, Brown JR, Payan DG, and Brown MA (1993). Substance P selectively activates TNF-alpha gene expression in murine mast cells. J Immunol 150:4478-4485.
4. Aoyagi T, Adachi K, Halprin KM, Levine V, and Woodyard CW (1981). The effect of histamine on epidermal outgrowth: Its possible dual role as an inhibitor and stimulator. J Invest Dermatol 76:24-27.
5. Argyris TS (1967). Hair growth induction by damage. Adv Biol Skin 9:339-345.
6. Baccaredda-Boy A and Giaccometti C (1962). Metachromasia, mast cells and thyrotropinemia in alopecia areata. Ital Gen Rev Dermatol 88:7-13.
7. Beele H, Thierens H, and Ridder L (1994). Dose-response curve of the effects of serotonin and ketanserin on the functional morphology of skin in vitro. Skin Pharmacol 7:181-187.
8. Bienenstock J (1995). Immune-and mast cell-interactions with nerves. In: Kitamura Y, Yamamoto S, Galli SJ, and Greaves MW, editors. Biological and molecular aspects of mast cell and basophil differentiation and function. New York: Raven Press, 173-182.
9. Botchkarev VA, Eichmüller S, Pietsch P, Johansson O, Maurer M, and Paus R (1997). A simple immunofluorescence-technique for simultaneous visualization of mast cells and reveals selectivity and hair cycle-dependent changes in mast cell-nerve fiber contacts in murine skin. Arch Dermatol Res 289:292-302.
10. Botchkarev VA, Paus R, Czarnetzki BM, Kupriyanov VS, Gordon DS, and Johansson O (1995). Hair cycle-dependent changes of mast cell histochemistry in murine skin. Arch Dermatol Res 287:683-686.
11. Brown WR and Hardy MH (1988). A hypothesis on the cause of chronic epidermal hyperproliferation in asebia mice. Clin Exp Dermatol 13:74-77.
12. Chase HB (1954). Growth of hair. Physiol Rev 34:113-126.
13. Couchman JR, McCarthy KJ, and Woods A (1991). Proteoglycans and glycoproteins in hair follicle development and cycling. Ann NY Acad Sci 642:243-252.
14. Dackiw APB, Nathens AB, Ribeiro MB, Cheung PYC, Marshall JC, and Rotstein OD (1995). Mast cell modulation of macrophage procoagulant activity and TNF production. J Surg Res 59:1-5.
15. Dayer JM, Beutler B, and Cerami A (1985). Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 162:2163-2168.
16. Detmar M and Orfanos CE (1990). Tumor necrosis factor-alpha inhibits cell proliferation and induces class II antigens and cell adhesion molecules in cultured normal human keratinocytes in vitro. Arch Dermatol Res 282:238-245.
17. Dvorak AM (1993a). Human mast cells: Ultrastructural observations of in situ, ex vivo, and in vitro sites, sources and systems. In: Kaliner MA and Metcalfe DD, editors. The mast cell in health and disease. New York: Marcel Dekker, 1-79.
18. Dvorak AM (1993b). Ultrastructural analysis of anaphylactic and piecemeal degranulation of human mast cells and basophils. In: Foreman JC, editor. Immunopharmacology of mast cells and basophils. London: Academic Press, 89-113.
19. Dvorak AM, Tepper RI, Weller PF, Morgan ES, Estrella P, Monahan-Earley RA, and Galli SJ (1994). Piecemeal degranulation of mast cells in the inflammatory eyelid lesions of interleukin-4 transgenic mice: Evidence of mast cell histamine release in vivo by diamine oxidase-gold enzyme-affinity ultrastructural cytochemistry. Blood 83:3600-3612.
20. Eady RA, Cowen T, Marshall TF, Plummer V, and Greaves MW (1979). Mast cell population density, blood vessel density and histamine content in normal human skin. Br J Dermatol 100:623-633.
21. Enerbäck L and Lowhagen G (1979). Long term increase in mucosal mast cells in rat induced by administration of compound 48/80. Cell Tissue Res 198:209-216.
22. Flaxman BA and Harper RA (1975). In vitro analysis of the control of keratinocyte proliferation in human epidermis by physiologic and pharmacologic agents. J Invest Dermatol 65:52-59.
23. Foreman JC (1993). Non-immunological stimuli of mast cells and basophil leucocytes. In: Foreman JC, editor, Immunopharmacology of mast cells and basophils. London: Academic Press, 57-65.
24. Galli SJ (1997). The mast cell: A versatile effector cell for a challenging world. Int Arch Allergy Immunol 113:14-22.
25. v mice. Blood 69:1661-1666.
26. Galli SJ, Tsai M, and Wershil BK (1993). The c-kit receptor, stem cell factor, and mast cells: What each is teaching us about the others. Am J Pathol 142:965-974.
27. Gibson WT, Westgate GE, and Craggs RI (1991). Immunology of the hair follicle. Ann NY Acad Sci 642:291-300.
28. Gilbert SF (1994). Developmental biology. New York: Sinauer Assoc., Inc., Sunderland.
29. ∈RI: A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses. J Exp Med 174:103-107.
30. ∈RI: Role for mast cell-derived transforming growth factor and tumor necrosis factor alpha. J Exp Med 180:2027-2037.
31. Grabbe J, Welker P, Dippel E, and Czarnetzki BM (1994). Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. Arch Dermatol Res 287:78-84.
32. Hansen LS, Coggle JE, Wells J, and Charles MW (1984). The influence of the hair cycle on the thickness of mouse skin. Anat Rec 210:569-573.
33. Hardy ME (1992). The secret life of the hair follicle. Trends Genet 8:55-61.
34. Harper RA and Flaxman BA (1975). Effect of pharmacologic agents on human keratinocyte mitosis in vitro. J Invest Dermatol 65:400-403.
35. Hood AF, Kwan TH, Mihm MC, and Horn TD (1993). A primer of dermatopathology. New York: Little, Brown and Company.
36. Irani AMA, Gruber BL, Kaufman LD, Kahaleh MB, and Schwartz LB (1992). Mast cell changes in scleroderma: Presence of MCT cells in the skin and evidence of mast cell activation. Arthritis Rheum 35:933-939.
37. Jaworsky C, Kligman AM, and Murphy GF (1992). Characterization of inflammatory infiltrates in male pattern alopecia: Implications for pathogenesis. Br J Dermatol 127:239-246.
38. Johnson HG and Bach MK (1975). Prevention of calcium ionophore-induced release of histamine in rat mast cells by disodium cromoglycate. J Immunol 114:514-516.
39. Juhlin L (1963). Reactions to infusion of a histamine liberator. Arch Dermatol 88:771-778.
40. Keller R, Hess MW, and Riley JW (1976). Mast cells in the skin of normal, hairless and athymic mice. Experientia 32:171-172.
41. Kendall JC, Li XH, Galli SJ, and Gordon JR (1997). Promotion of mouse fibroblast proliferation by IgE-dependent activation of mouse mast cells: Role for mast cell tumor necrosis factor-alpha and transforming growth factor-beta 1. J Allergy Clin Immunol 99:113-123.
42. Kielty CM, Lees M, Shuttleworth CA, and Woolley D (1993). Catabolism of intact type VI collagen microfibrils: Susceptibility to degradation by serine proteinases. Biochem Biophys Res Commun 191:1230-1236.
43. Krejci NC, Knapp DM, Rudd RJ, Bauer EA, and McGuire J (1992). Dermal mast cell granules bind interstitial procollagenase and collagenase. J Invest Dermatol 98:748-752.
44. Lattanand A and Johnson WC (1975). Male pattern alopecia: A histopathologic and histochemical study. J Cutan Pathol 2:58-70.
45. Lees M, Taylor DJ, and Woolley DE (1994). Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinase A and B. Eur J Biochem 223:171-177.
46. Levi-Schaffer F (1995). Mast cell/fibroblast interactions in health and disease. In: Marone G, editor. Human basophils and mast cells: Biological aspects. Basel: Karger, 161-180.
47. Maekawa Y (1979). Dermal glycosaminoglycan concentration throughout hair growth cycle of rats. J Dermatol 6:191-195.
48. Malkani AK, Baker BS, Garioch JJ, Powles AV, Lewis HM, Valdimarsson H, and Fry L (1993). Normal response to tumor necrosis factor-alpha and transforming growth factor-beta by keratinocytes in psoriasis. Exp Dermatol 2:224-230.
49. Mansbridge JN and Hanawalt PC (1995). Role of transforming growth factor beta in the maturation of human epidermal keratinocytes. J Invest Dermatol 90:336-341.
50. Marshall JS, Stead RH, McSharry C, Nielsen I, and Bienenstock J (1990). The role of mast cell degranulation products in mast cell hyperplasia: The mechanism of action of nerve growth factor. J Immunol 144:1886-1892.
51. Matsumoto K, Hashimoto K, Hashiro M, Yoshimasa H, and Yoshikawa K (1990). Modulation of growth and differentiation in normal human keratinocytes by transforming growth factor-beta. J Cell Physiol 145:95-101.
52. Maurer M, Handjiski B, and Paus R (1997a). Hair growth modulation by topical immunophilin ligands: Induction of anagen, Inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia. Am J Pathol 150:1433-1441.
53. Maurer M, Opitz M, Henz BM, and Paus R (in press, 1997b). The mast cell products histamine and serotonin stimulate and TNF-alpha inhibits the proliferation of murine epidermal keratinocytes in situ. J Dermatol Sci.
54. Maurer M, Paus R, and Czarnetzki BM (1995). Mast cells as modulators of hair follicle cycling. Exp Dermatol 4:266-271.
55. Maurer M, Peters EMJ, Fischer E, Botchkarev V, Eichmueller S, and Paus R (1996). The role of neuropeptides in murine hair cycle modulation: Induction of hair follicle regression (catagen) by capsaicin and substance P (abstract). J Invest Dermatol 107:489.
56. Mayer U, Mann K, Timpl R, and Murphy G (1993). Sites of nidogen cleavage by proteases involved in tissue homeostasis and remodelling. Eur J Biochem 217:877-884.
57. Morelli JG and Norris DA (1993). Influence of inflammatory mediators and cytokines on human melanocyte function. J Invest Dermatol 100:191S-195S.
58. Moretti G, Cipriani C, Rebora A, Rampini E, and Crovato F (1967). Correlations of tissue mucopolysaccharides with the hair cycle. J Invest Dermatol 48:498-503.
59. Moretti G, Giacometti C, Boido V, and Rebora A (1963). Histamine, serotonin and mast cells in the skin of the rat during the hair cycle. J Invest Dermatol 40:205-212.
60. Nagano K, Hori K, Sugawara T, Oh-ishi J, Hayashi H, Watanabe N, and Niitsu Y (1990). Effect of tumor necrosis factor in the mouse-tail model of psoriasis. Arch Dermatol Res 282:459-462.
61. Orr TS and Cox JS (1969). Disodium cromoglycate, an inhibitor of mast cell degranulation and histamine release induced by phospholipase A. Nature 223:197-198.
62. Paus R (1991). Hair growth inhibition by heparin in mice: A model system for studying the modulation of epithelial cell growth by glycosaminoglycans? Br J Dermatol 124:415-422.
63. Paus R (1996). Control of the hair cycle and hair diseases as cycling disorders. Curr Opin Dermatol 3:248-258.
64. Paus R, Handjiski B, Czarnetzki BM, and Eichmüller S (1994a). A murine model for inducing and manipulating hair follicle regression (catagen): Effects of dexamethasone and cyclosporin A. J Invest Dermatol 103:143-147.
65. Paus R, Handjiski B, Eichmüller S, and Czarnetzki BM (1994b). Chemotherapy-induced alopecia in mice: Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone. Am J Pathol 144:719-734.
66. Paus R, Heinzelmann T, Robiscek T, Czarnetzki BM, and Maurer M (1995). Substance P stimulates murine epidermal keratinocyte proliferation and dermal mast cell degranulation in situ. Arch Dermatol Res 287:500-502.
67. Paus R, Heinzelmann T, Schultz KD, Furkert J, Fechner K, and Czarnetzki BM (1994c). Hair growth induction by substance P. Lab Invest 71:134-140.
68. Paus R, Krejci-Papa N, Li L, Czarnetzki BM, and Hoffman RM (1994d). Correlation of proteolytic activities of organ cultured intact mouse skin with defined hair cycle stages. J Dermatol Sci 7:202-209.
69. Paus R, Lüftl M, and Czarnetzki BM (1994e). Nerve growth factor modulates keratinocyte proliferation in murine skin organ culture. Br J Dermatol 130:174-180.
70. Paus R, Maurer M, Slominski A, and Czarnetzki BM (1994f). Mast cell involvement in murine hair growth. Dev Biol 163: 230-240.
71. Paus R, Stenn KS, and Link RE (1990). Telogen skin contains an inhibitor of hair growth. Br J Dermatol 122:777-784.
72. Pietenpol JA, Holt JT, Stein RW, and Moses HL (1990). Transforming growth factor betal suppression of c-myc gene transcription: Role in inhibition of keratinocyte proliferation. Proc Natl Acad Sci USA 87:3758-3762.
73. Piguet PF, Grau GE, and Vassalli P (1990). Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis. Am J Pathol 136:103-110.
74. Reed RJ, Clark WH, and Mihm MC (1973). The cutaneous mucinosis. Hum Pathol 4:201-212.
75. Ridder L and Beele H (1988). Morphological effects of serotonin and ketanserin on embryonic chick skin in vitro. Experientia 44:603-607.
76. Rook A and Dawber R (1991). Diseases of the hair and scalp. Oxford: Oxford University Press.
77. Saarinen J, Kalkkinen N, Welgus HG, and Kovanen PT (1994). Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase. J Biol Chem 269:18134-18140.
78. Schwarz A, Bhardwaj R, Aragane Y, Mahnke K, Riemann R, Metze D, and Luger TA (1995). Ultraviolet-B-induced apoptosis of keratinocytes: Evidence for partial involvement of tumor necrosis factor-alpha in the formation of sunburn cells. J Invest Dermatol 104:922-927.
79. Slominski A, Paus R, Plonka P, Chakraborty A, Maurer M, Pruski D, and Lukiewicz S (1994). Melanogenesis during the anagen-catagen-telogen transformation of the murine hair cycle. J Invest Dermatol 102:862-869.
80. Straile WE, Chase HB, and Arsenault C (1961). Growth and differentiation of hair follicles between periods of activity and quiescence. J Exp Zool 148:205-216.
81. Sunberg JP (1994). Handbook of mouse mutations with skin and hair abnormalities: Animal models and biomedical tools. New York: CRC Press.
82. Swope VB, Abdel-Malek Z, Kassem LM, and Nordlund JJ (1991). Interleukins 1 alpha and 6 and tumor necrosis factor-alpha are paracrine inhibitors of human melanocyte proliferation and melanogenesis. J Invest Dermatol 96:180-185.
83. Thompson HL, Burbelo PD, Gabriel G, Yamada Y, and Metcalfe DD (1991). Murine mast cells syntesize basement membrane components: A potential role in early fibrosis. J Clin Invest 87:619-625.
84. Tsai M, Takeishi T, Thompson H, Langley KE, Zsebo KM, Metcalfe DD, Geissler EN, and Galli SJ (1991). Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci USA 88:6382-6386.
85. Vandenabeele P, Declercq W, Vanhaesebroeck B, Grooten J, and Fiers W (1995). Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells. J Immunol 154:2904-2913.
86. Voelkel-Johnson C, Entingh AJ, Wold WS, Gooding LR, and Laster SM (1995). Activation of intracellular proteases is an early event in TNF-induced apoptosis. J Immunol 154:1707-17016.
87. Weber S, Krueger-Krasagakes S, Grabbe J, Zuberbier T, and Czarnetzki BM (1995). Mast cells. Int J Dermatol 34:1-10.
88. Weinberg WC, Brown PD, Stetler-Stevenson WG, and Yuspa SH (1990). Growth factors specifically alter hair follicle cell proliferation and collagenolytic activity alone or in combination. Differentiation 45:168-178.
89. Welton AF, Hope WC, O'Donnell M, Baruth H, Crowley HJ, Miller DA, and Yaremko B (1984). Ro 22-3747: A new antiallergic agent for the treatment of immediate hypersensitivity diseases. J Pharmacol Exp Ther 228:57-64.
90. Wershil BK, Murakami T, and Galli SJ (1988). Mast cell-dependent amplification of an immunologically nonspecific inflammatory response: Mast cells are required for the full expression of cutaneous acute inflammation of 12-myristate 13-acetate. J Immunol 140:2356-2360.
91. Yano H, Wershil BK, Arizono N, and Galli SJ (1989). Substance P-induced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell dependent. J Clin Invest 84:1276-1286.
92. Yee NS, Hsiau C-WM, Serve H, Vosseller K, and Besmer P (1994). Mechanisms of down-regulation of c-Kit receptor. J Biol Chem 269:31991-31998.
93. Yee NS, Langen H, and Besmer P (1993). Mechanisms of kit ligand, phorbol ester, and calcium-induced down-regulation of c-Kit receptors in mast cells. J Biol Chem 268:14189-14201.